All TechFacts |
G500 Pharmaceuticals: Spend before and after Ariba |
|
A Global 500 pharmaceuticals company actively managed 30% of its spend before utilizing Ariba and now manages 75%, a 150% increase in active spend management. |
150% Increase |
| Source: | Executive, Global 500 Pharmaceuticals Company | TVID: A72-3EC-9ED |
Share...
Share This TechFact Via...
Email
Twitter
Facebook
LinkedIn
Tip: You can also copy and paste this link to share this TechFact:
http://www.techvalidate.com/product-research/ariba-spend-management/facts/A72-3EC-9ED
Embed
Download
What's a TechFact?
TechFacts are TechValidate Research Findings – real-world statements, testimonials, statistics, and diagrams sourced from verified users of a technology product or service about how organizations have deployed and use it.
TechValidate verifies the identity and organizational affiliation of all users involved and guarantees their anonymity so that they can speak candidly.
Source Data
This research finding was sourced directly from a verified user of Ariba Spend Management Solution by TechValidate. We verify the identity and organizational affiliation of all research participants while guaranteeing anonymity so that people can speak freely.
Respondent Info: Executive, Global 500 Pharmaceuticals Company
